華強科技(688151.SH):預灌封注射器用橡膠組件是預灌封注射器中的關鍵部件
格隆匯7月26日丨有投資者向華強科技(688151.SH)提問:據瞭解,預灌封注射器用橡膠組件是公司核心技術之一,可否簡要介紹下預灌封的原理?
華強科技回覆:預灌封是將注射藥物直接灌裝在注射器中,將注射器和藥液包裝容器合二為一,使用時直接注射。預灌封注射器是一種新型的藥品包裝形式,同時具有儲存藥物和普通注射兩種作用,能夠有效降低藥物因儲存及轉移過程的吸附造成的浪費和二次污染,通常用於疫苗等特殊藥品的包裝,是未來注射製劑藥品包裝的趨勢。預灌封注射器用橡膠組件是預灌封注射器中的關鍵部件,直接關係到預灌封注射器的質量,預灌封注射器用橡膠組件製造技術是公司自主研發,主要包括預灌封注射器用活塞、預灌封注射器用覆膜活塞、預灌封注射器用針頭護帽等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.